120 related articles for article (PubMed ID: 26386519)
1. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma.
Bell D; Aung P; Prieto VG; Ivan D
Ann Diagn Pathol; 2015 Dec; 19(6):381-4. PubMed ID: 26386519
[TBL] [Abstract][Full Text] [Related]
2. Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature.
Knackstedt RW; Knackstedt TJ; Findley AB; Piliang M; Jellinek NJ; Bernard SL; Vidimos A
Int J Dermatol; 2017 Oct; 56(10):1061-1064. PubMed ID: 28832985
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma.
Surowy HM; Giesen AK; Otte J; Büttner R; Falkenstein D; Friedl H; Meier F; Petzsch P; Wachtmeister T; Westphal D; Wieczorek D; Wruck W; Adjaye J; Rütten A; Redler S
Br J Dermatol; 2019 May; 180(5):1150-1160. PubMed ID: 30472730
[TBL] [Abstract][Full Text] [Related]
4. A Case Report of Papillary Digital Adenocarcinoma With BRAFV600E Mutation and Quantified Mutational Burden.
Trager MH; Jurkiewicz M; Khan S; Niedt GW; Geskin LJ; Carvajal RD
Am J Dermatopathol; 2021 Jan; 43(1):57-59. PubMed ID: 32568833
[TBL] [Abstract][Full Text] [Related]
5. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
J Cutan Pathol; 1987 Jun; 14(3):129-46. PubMed ID: 3301927
[TBL] [Abstract][Full Text] [Related]
6. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma.
Feldmeyer L; Prieto VG; Ivan D; Nagarajan P; Tetzlaff MT; Curry JL; Bell D; Moon BS; Torres-Cabala CA; Aung PP
Ann Clin Lab Sci; 2016; 46(2):222-4. PubMed ID: 27098633
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-58 and -73-associated digital squamous cell carcinoma in a patient with aggressive digital papillary adenocarcinoma.
DePond W; Kure K; Lankachandra K; Gidwani R; Nelson BV; Zimmerman H; Talboy GE; Miranda RN
Am J Dermatopathol; 2009 Jun; 31(4):375-8. PubMed ID: 19461243
[TBL] [Abstract][Full Text] [Related]
8. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
Santarpia L; Sherman SI; Marabotti A; Clayman GL; El-Naggar AK
Hum Pathol; 2009 Jun; 40(6):827-33. PubMed ID: 19200582
[TBL] [Abstract][Full Text] [Related]
9. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH
Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
[TBL] [Abstract][Full Text] [Related]
10. Aggressive digital papillary adenocarcinoma: a review.
Hsu HC; Ho CY; Chen CH; Yang CH; Hong HS; Chuang YH
Clin Exp Dermatol; 2010 Mar; 35(2):113-9. PubMed ID: 19874325
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
12. Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection.
Bui CM; Pukhalskaya T; Smoller BR; Zengin HB; Heneidi S; Vail E; Makhoul E; Balzer B
J Cutan Pathol; 2023 Jun; 50(6):568-576. PubMed ID: 36756976
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns.
Jakubowski M; Hunt JL
Am J Surg Pathol; 2009 Nov; 33(11):1590-3. PubMed ID: 19738460
[TBL] [Abstract][Full Text] [Related]
14. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
Gauchotte G; Philippe C; Lacomme S; Léotard B; Wissler MP; Allou L; Toussaint B; Klein M; Vignaud JM; Bressenot A
Pathology; 2011 Aug; 43(5):447-52. PubMed ID: 21716161
[TBL] [Abstract][Full Text] [Related]
15. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.
Lee X; Gao M; Ji Y; Yu Y; Feng Y; Li Y; Zhang Y; Cheng W; Zhao W
Ann Surg Oncol; 2009 Feb; 16(2):240-5. PubMed ID: 19034577
[TBL] [Abstract][Full Text] [Related]
16. Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer.
Wang Y; Ji M; Wang W; Miao Z; Hou P; Chen X; Xu F; Zhu G; Sun X; Li Y; Condouris S; Liu D; Yan S; Pan J; Xing M
Endocr Relat Cancer; 2008 Mar; 15(1):183-90. PubMed ID: 18310286
[TBL] [Abstract][Full Text] [Related]
17. An aggressive treatment for aggressive digital papillary adenocarcinoma.
Inaloz HS; Patel GK; Knight AG
Cutis; 2002 Mar; 69(3):179-82; quiz 210. PubMed ID: 11926336
[TBL] [Abstract][Full Text] [Related]
18. Aggressive digital papillary adenocarcinoma: A clinicopathological study of 19 cases.
Weingertner N; Gressel A; Battistella M; Cribier B
J Am Acad Dermatol; 2017 Sep; 77(3):549-558.e1. PubMed ID: 28495496
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
[TBL] [Abstract][Full Text] [Related]
20. Digital papillary adenoma (ADPA) and aggressive digital papillary adenocarcinoma (AdPACa).
Gorva AD
Am J Dermatopathol; 2005 Dec; 27(6):546-7; author reply 547. PubMed ID: 16314709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
